Suppr超能文献

在不收集尿液的情况下估算透析患者的残余肾功能。

Estimating residual kidney function in dialysis patients without urine collection.

作者信息

Shafi Tariq, Michels Wieneke M, Levey Andrew S, Inker Lesley A, Dekker Friedo W, Krediet Raymond T, Hoekstra Tiny, Schwartz George J, Eckfeldt John H, Coresh Josef

机构信息

Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA; Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland, USA.

Division of Nephrology, Department of Medicine, Academic Medical Center, Amsterdam, the Netherlands.

出版信息

Kidney Int. 2016 May;89(5):1099-1110. doi: 10.1016/j.kint.2015.10.011. Epub 2016 Jan 21.

Abstract

Residual kidney function contributes substantially to solute clearance in dialysis patients but cannot be assessed without urine collection. We used serum filtration markers to develop dialysis-specific equations to estimate urinary urea clearance without the need for urine collection. In our development cohort, we measured 24-hour urine clearances under close supervision in 44 patients and validated these equations in 826 patients from the Netherlands Cooperative Study on the Adequacy of Dialysis. For the development and validation cohorts, median urinary urea clearance was 2.6 and 2.4 ml/min, respectively. During the 24-hour visit in the development cohort, serum β-trace protein concentrations remained in steady state but concentrations of all other markers increased. In the validation cohort, bias (median measured minus estimated clearance) was low for all equations. Precision was significantly better for β-trace protein and β2-microglobulin equations and the accuracy was significantly greater for β-trace protein, β2-microglobulin, and cystatin C equations, compared with the urea plus creatinine equation. Area under the receiver operator characteristic curve for detecting measured urinary urea clearance by equation-estimated urinary urea clearance (both 2 ml/min or more) were 0.821, 0.850, and 0.796 for β-trace protein, β2-microglobulin, and cystatin C equations, respectively; significantly greater than the 0.663 for the urea plus creatinine equation. Thus, residual renal function can be estimated in dialysis patients without urine collections.

摘要

残余肾功能对透析患者的溶质清除有很大贡献,但不进行尿液收集就无法评估。我们使用血清滤过标志物来开发特定于透析的方程,以在无需尿液收集的情况下估算尿尿素清除率。在我们的开发队列中,我们在密切监督下测量了44例患者的24小时尿液清除率,并在荷兰透析充分性合作研究的826例患者中验证了这些方程。对于开发队列和验证队列,尿尿素清除率中位数分别为2.6和2.4 ml/分钟。在开发队列的24小时访视期间,血清β-微球蛋白浓度保持稳定,但所有其他标志物的浓度均升高。在验证队列中,所有方程的偏差(测量的中位数减去估计的清除率)都很低。与尿素加肌酐方程相比,β-微球蛋白和β2-微球蛋白方程的精密度明显更好,β-微球蛋白、β2-微球蛋白和胱抑素C方程的准确性明显更高。通过方程估计的尿尿素清除率检测测量的尿尿素清除率(均为2 ml/分钟或更高)的受试者工作特征曲线下面积,β-微球蛋白、β2-微球蛋白和胱抑素C方程分别为0.821、0.850和0.796;明显大于尿素加肌酐方程的0.663。因此,无需尿液收集即可估算透析患者的残余肾功能。

相似文献

1
Estimating residual kidney function in dialysis patients without urine collection.
Kidney Int. 2016 May;89(5):1099-1110. doi: 10.1016/j.kint.2015.10.011. Epub 2016 Jan 21.
2
Predicting residual kidney function in hemodialysis patients using serum β-trace protein and β2-microglobulin.
Kidney Int. 2016 May;89(5):1090-1098. doi: 10.1016/j.kint.2015.12.042. Epub 2016 Feb 26.
4
GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD.
Am J Kidney Dis. 2016 Jan;67(1):40-8. doi: 10.1053/j.ajkd.2015.07.025. Epub 2015 Sep 9.
5
Plasma Levels of Middle Molecules to Estimate Residual Kidney Function in Haemodialysis without Urine Collection.
PLoS One. 2015 Dec 2;10(12):e0143813. doi: 10.1371/journal.pone.0143813. eCollection 2015.
7
Prognostic Value of Residual Urine Volume, GFR by 24-hour Urine Collection, and eGFR in Patients Receiving Dialysis.
Clin J Am Soc Nephrol. 2017 Mar 7;12(3):426-434. doi: 10.2215/CJN.05520516. Epub 2017 Feb 22.
8
Estimation of residual renal function using beta-trace protein: Impact of dialysis procedures.
Artif Organs. 2020 Jun;44(6):647-654. doi: 10.1111/aor.13641. Epub 2020 Mar 5.
9
Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in the Elderly: AGES-Kidney and MESA-Kidney.
Am J Kidney Dis. 2017 Sep;70(3):406-414. doi: 10.1053/j.ajkd.2017.03.021. Epub 2017 May 24.
10

引用本文的文献

2
Reference interval of free light chains ratio in patients with end-stage renal disease on chronic hemodialysis.
Haematologica. 2024 Nov 1;109(11):3751-3754. doi: 10.3324/haematol.2024.285093.
3
Twice Weekly versus Thrice Weekly Hemodialysis-A Pilot Cross-Over Equivalence Trial.
Clin J Am Soc Nephrol. 2024 Sep 1;19(9):1159-1168. doi: 10.2215/CJN.0000000000000507. Epub 2024 Jun 26.
4
Predicting solute transfer rate in patients initiating peritoneal dialysis.
J Nephrol. 2024 May;37(4):973-982. doi: 10.1007/s40620-023-01862-y. Epub 2024 Jan 30.
5
Dialysis for older adults: why should the targets be different?
J Nephrol. 2024 May;37(4):841-850. doi: 10.1007/s40620-023-01835-1. Epub 2024 Jan 5.
6
A Review of Residual Kidney Function in Peritoneal Dialysis Patients.
Indian J Nephrol. 2023 Jul-Aug;33(4):239-246. doi: 10.4103/ijn.ijn_242_23. Epub 2023 Aug 16.
7
Choice of the Dialysis Modality: Practical Considerations.
J Clin Med. 2023 May 7;12(9):3328. doi: 10.3390/jcm12093328.
8
On the importance of the interplay of residual renal function with clinical outcomes in end-stage kidney disease.
J Nephrol. 2022 Dec;35(9):2191-2204. doi: 10.1007/s40620-022-01388-9. Epub 2022 Jul 11.
9
Association between serum β2-microglobulin and mortality in Japanese peritoneal dialysis patients: A cohort study.
PLoS One. 2022 Apr 14;17(4):e0266882. doi: 10.1371/journal.pone.0266882. eCollection 2022.

本文引用的文献

1
KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update.
Am J Kidney Dis. 2015 Nov;66(5):884-930. doi: 10.1053/j.ajkd.2015.07.015.
2
GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD.
Am J Kidney Dis. 2016 Jan;67(1):40-8. doi: 10.1053/j.ajkd.2015.07.025. Epub 2015 Sep 9.
3
Plasma Iohexol Clearance for Assessing Residual Kidney Function in Dialysis Patients.
Am J Kidney Dis. 2015 Oct;66(4):728-30. doi: 10.1053/j.ajkd.2015.06.010. Epub 2015 Jul 21.
4
β-Trace protein: a marker of GFR and other biological pathways.
Am J Kidney Dis. 2015 Jan;65(1):131-46. doi: 10.1053/j.ajkd.2014.06.038. Epub 2014 Oct 22.
5
C-terminal agrin fragment (CAF) as a serum biomarker for residual renal function in peritoneal dialysis patients.
Int Urol Nephrol. 2015 Feb;47(2):391-6. doi: 10.1007/s11255-014-0852-5. Epub 2014 Oct 29.
6
The kinetics of cystatin C removal by hemodialysis.
Am J Kidney Dis. 2015 Jan;65(1):174-5. doi: 10.1053/j.ajkd.2014.08.010. Epub 2014 Oct 3.
7
Estimating glomerular filtration rate from serum creatinine and cystatin C.
N Engl J Med. 2012 Jul 5;367(1):20-9. doi: 10.1056/NEJMoa1114248.
9
Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structural model.
Nephrol Dial Transplant. 2011 Sep;26(9):2978-83. doi: 10.1093/ndt/gfq856. Epub 2011 Feb 11.
10
Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation.
Scand J Clin Lab Invest. 2011 Apr;71(2):145-9. doi: 10.3109/00365513.2010.546879. Epub 2011 Jan 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验